COVID-19: AstraZeneca vaccine to be tested on children 'as young as six' in new trials

University of Oxford anunced Saturday that it will conduct clinical trials of COVID-19 vaccine on children as young as 6 years old up to 17 to test vaccine’s efficacy in young people. Researchers will recruit at least 300 kid volunteers for assessment of level of immune response jabs produce in children. University of Oxford and its partners are expected to commence tests this weekend at Oxford University and its partner sites in London, Southampton, and Bristol. Thus far, firm revealed that up to 240 kids expected to receive COVID-19 vaccine and reaming, meningitis iculation. Pfizer and Moderna, meanwhile have also started enrolling kids d 12 and above for clinical trials to determine if vaccines could provide children life-long immunity from COVID-19 disease. 

Re: Scientists Seek To Develop All-in One-vaccine As COVID-19 Mutations Spre Rapidly

Re: Covid Vaccine Booster Shot: Second Round Of Iculation To Start Across India Today

In a statement on Saturday, University of Oxford said that it was w enrolling volunteers from Thames Valley area for clinical trials on kids. “ purpose of this study is to test a new vaccine against COVID-19 in children and young ults d 6-17 years,” it informed. Furr, university ded, “This study will enable us to assess if children can be protected from COVID-19 with this new vaccine called ChOx1 nCoV-19. It will also give us valuable information on safety aspects of vaccine and its ability to generate good immune responses against virus, in children and young people.” researchers will randomly allocate participants to receive COVID-19 vaccine, and will furr monitor health and perform blood tests, and will collect or information about any symptoms that occur after vaccination procedure. “Participants from Black, Asian and Mirity Ethnic groups are particularly welcomed to participate in this study,” university said. 

Child must have ' medical history'

According to University of Oxford’s release, any kid will be eligible to participate in vaccine trial if y resided near one of centers in Oxford, St George’s University Hospital, London, Southampton, or Bristol. It ded, that child must have “  significant medical history” and must be d between 6 years and 17 years and 8 months. “we will recruit a total of 300 participants, of which up to 240 will be vaccinated with candidate vaccine ChOx1 nCoV-19, and up to 60 will be vaccinated with a control vaccine (MenB, Bexsero),” Oxford said, ding that participants will remain uniformed about ir group. “ data from this study may be used to support furr larger scale trials in children, results of which may be used by AstraZeneca to support approvals of this vaccine for use in children in future,” release re. 

Re: Angela Merkel Responds To Vaccine Roll-out Critics; Assures Full House At Centres By April

Re: France Recommends 'one-shot Vaccine'' For People Who Recovered From COVID-19

(Im Credit: Unsplash/Representative im)